REVIEW PAPER - Environmental chemical risk factors of breast cancer in Nigeria I: Broad overview

Yetunde M. Olumide, Olusola O. Ayanlowo, Ayesha O. Akinkugbe, Erereoghor Otrofanowei


Nigeria is currently experiencing a most disturbing level of incidence rate, morbidity and mortality from the ravages of female breast cancer, with its attendant burden of emotional, social and financial consequences. Tens of thousands of chemicals make their way into our everyday products and environment, with little regard for safety. The need to explore the impact of adverse environmental chemical exposures to breast health in Nigeria informed this study as there is need for public health approach to long term prevention.

After exploring the robust scientific database on environmental chemical risk factors for female breast cancer, we found that many mammary toxicants are ubiquitous in our environment in Nigeria but have been taken for granted as inevitable in normal life exposures. This study identifies some of the potential environmental chemical risk factors of breast cancer in Nigeria. We describe the special exposure scenarios in Nigeria and prescribe some modest but practical ways to mitigate exposures. The factors that constitute risk to breast cancer could potentially be modified either through community education or government action and regulation. The subject is discussed in multiple Parts before releasing the manuscripts for publication to prevent criminalizing only a few chemicals if discussed and published to the exclusion of others.

To our knowledge, this is the first ever comprehensive work on the subject in the African continent and is useful to typical developing countries as are found in sub-Saharan countries and elsewhere since findings and recommendations are usually generic in nature and mutually beneficial.


Breast cancer, environmental chemical(s), risk factors (Nigeria)

Full Text:



Jemal A, Bray F, Center MM, Ferlay J, Ward E, & Forman D (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians. 61:69–90.

American Cancer Society (2017). Breast Cancer Facts & Figures 2017-2018 [Internet]. Atlanta: American Cancer Society, Inc.; [cited 2021 Dec 6]. Available from:

Interagency Breast Cancer and Environment Research Coordinating Committee (IBCERCC) (2013). Breast Cancer and the Environment: Prioritizing Prevention. [Internet]. [cited 2021 Dec 6]. Available from:

Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood MJ, Tsukuma H, Koifman S, Silva GAE, Francisci S, Santaquilani M, Verdecchia A, Storm HH, & Young JL(2008). Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncology. 9:730–756.

Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, Hartman Ar, Winter EP, & Garba JE (2016). Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. Journal of Clinical Oncology. 34:1460.

Turnbull C & Rahman N (2008). Genetic predisposition to breast cancer: past, present, and future. Annual Review of Genomics and Human Genetics. 9:321–345.

Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, & Hemminki K (2000). Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark, and Finland. The New England Journal of Medicine. 343:78–85.

Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, & Hyer MB (1993). Migration Patterns and Breast Cancer Risk in Asian-American Women. Journalof the National Cancer Institute. 85:1819–1827.

Parkin DM, Bray F, Ferlay J, & Pisani P (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. 55:74–108.

Hiatt RA & Brody JG (2018). Environmental Determinants of Breast Cancer. Annual Review of the Public Health. 39:113–133.

Hiatt RA, Porco TC, Liu F, Balke K, Balmain A, Barlow J, Braithwaite D, Diez-Roux AV, Kushi LH, Moasser MM, Werb Z, Windham GC, & Rehkopf DH (2014). A Multilevel Model of Postmenopausal Breast Cancer Incidence. Cancer Epidemiology Biomarkers& Prevention. 23:2078–2092.

Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Cronin KA, Lake A,Noone AM, Henley SJ, Eheman CR, Anderson RN, & Penberthy L (2015). Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. Journal of the National Cancer Institute. 107.

Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, & Rudel RA (2007). Environmental pollutants and breast cancer. Cancer. 109:2667–2711.

Davis DL, Axelrod D, Bailey L, Gaynor M, & Sasco AJ (1998). Rethinking breast cancer risk and the environment: The case for the precautionary principle. Environmental Health Perspectives. 106:523–529.

Institute of Medicine (2012). Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press.

Gray JM, Rasanayagam S, Engel C, & Rizzo J (2017). State of the evidence 2017: an update on the connection between breast cancer and the environment. Environmental Health.16:94.

Rodgers KM, Udesky JO, Rudel RA, & Brody JG (2018). Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environmental Research. 160:152–182.

Cohn BA, La Merrill M, Krigbaum NY, Yeh G, Park JS, Zimmermann L, & Cirillo PM (2015). DDT Exposure in Utero and Breast Cancer. The Journal of Clinical Endocrinology and Metabolism.

Cohn BA, Terry MB, Plumb M, & Cirillo PM (2012). Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50. Breast Cancer Research Treatment. 136:267–275

Cohn A, Wolff MS, Cirillo PM, & Sholtz RI (2007). DDT and breast cancer in young women: new data on the significance of age at exposure. Environmental Health Perspectives. 115:1406–1414.

Rudel RA, Ackerman JM, Attfield KR, & Brody JG (2014). New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: a systematic approach based on animal evidence. Environ. Health Perspect.

Rudel RA, Artfield KR, Schifano JN, & Brody JG (2007). Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing and risk assessment for breast cancer prevention. Cancer 109:2635-2666

Rudel RA, Fenton SE, Ackerman JM, Euling SY, & Makris SL (2011). Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environmental Health Perspectives 119:1053-1061.

Soto Ana AM & Sonnenschein C (2010). Environmental causes of cancer: endocrine disruptors as carcinogens. Natural Reviews Endocrinology. 6:363-370

WHO, UNEP. State of the Science of Endocrine Disrupting Chemicals-2012. Edited by Ake Bergman, Jerrold J. Heindel, Susan Jobling, Karen A Kidd and R. Thomas Zoeller.

Bennett LM & Davis BJ (2002). Identification of mammary carcinogens in rodent bioassays. Environmental and Molecular Mutagenesis 39:150-7

Institute of Medicine (2012). Breast Cancer and the Environment: A Life Course Approach. SUMMARY. Environmental Factors Included in the Committee’s Evidence Review. National Academy of Sciences. Washington, DC: The National Academies Press.


Gore AC, Crews D, Doan LL, Merrill ML, Patisaul H, & Zota A. (2014). Introduction to Endocrine Disrupting Chemicals (EDCs). A guide for public interest organizations and policy-makers. Endocrine Society. IPEN.

Jacqueline S (2005). A present for life: hazardous chemicals in umbilical cord blood.

UNEP (2010). Ridding the world of POPs: A guide to the Stockholm Convention on Persistent Organic Pollutants. UNITED NATIONS, UNEP, Stockholm Convention.

Nicole W (2015). Identifying Potential Breast Carcinogens: A New Approach. Environmental Health Perspective. 123: A305. doi:10.1289/ehp.123-A305

SILENT SPRING INSTITUTE (2007). Mammary Carcinogens List.

Kimberly C (2014). New exposure biomarkers enhance breast cancer research. Environmental Factor. National Institute of Environmental Health Sciences.

Russo J & Russo IH (2006). The role of estrogen in the initiation of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 102(1-5):89-96.

Travis RC & Key TJ (2003). Oestrogen exposure and breast cancer risk. Breast Cancer Research. 5:239-247 (DOI 10.1186/bcr628)

Huber G (2015). Dirty Dozen Endocrine Disruptors. 12 Hormone-Altering Chemicals and How to avoid them. Environmental Working Group EWG.


Pesticide Action Network UK (2009). The List of Lists. A Catalogue of lists of pesticides identifying those associated with particularly harmful or environmental impacts. PAN UK. The List of Lists – 3rd edition.

World Health Organization. UNEP. United Nations Environment Programme. State of the Science of Endocrine Disrupting Chemicals—2012. Edited by Ake Bergman, Jerrold J Heindel, Susan Jobling, Karen A Kidd, & Thomas Zoeller. IOMC Inter-Organization Programme for the Sound Management of Chemicals. A Cooperative agreement among FAO, ILO, UNDP, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD.

Rice KM, Walker EM, Wu M, Gillette C, & Blough ER (2014) Environmental Mercury and Its Toxic Effects. Journal of Preventive Medicine and Public Health. 47:74.

Choe SY, Kim SJ, Kim HG, Lee JH, Choi Y, Lee H, & Yangho K. (2003) Evaluation of estrogenicity of major heavy metals. Science of Total Environment. 312:15-21.

Gaudet HM, Christensen E, Conn B, Morrow S, Cressey L, & Benoit J (2018) Methylmercury promotes breast cancer cell proliferation. Toxicology Reports 5: 579-584

US EPA (2015). Endocrine Disruptor Screening Program (EDSP) Estrogen Receptor Bioactivity.

Messenger J, Clark S, Massick S, & Bechtel M. (2013) A Review of Trimethylaminuria: (Fish Odor Syndrome). The Journal of Clinical and Aesthetic Dermatology 6: 45.

Barr L, Alamer M, & Darbre PD (2018) Measurement of concentrations of four chemical ultraviolet filters in human breast tissue at serial locations across the breast. Journal of Applied Toxicology 38: 1112-1120.

Krause, M, Klit A, Jensen MB, Søeborg T, Frederiksen H, Schlumpf M, Lichtensteiger W, Skakkebaek NE, & Drzewiecki KT. (2012) Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UVfilters.” International Journal of Andrology 35: 424-436.

Lorigo M, Mariana M, & Cairrao E (2018) Photoprotection of ultraviolet-B filters: Updated review of endocrine disrupting properties.” Steroids 131: 46-58.

Hyungjoo K, Donghwan J, Sunhwa O, KeeSoo N, Son S, Gye MC, & Shin I. (2019) Titanium dioxide nanoparticles induce apoptosis by interfering with EGFR signaling in human breast cancer cells. Environmental Research. 175: 117-123.

Bocca B, Pino A, Alimonti A, & Forte G (2014) Toxic metals contained in cosmetics: A status report. Regulatory Toxicology and Pharmacology 68: 447-467.

Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL, Karlan BY, Kaufman R, Noller KL, Palmer JR, Robboy SJ, Saal RC, Strohsnitter W, Titus-Ernstoff L, & Troisi R (2011). Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol. The New England Journal of Medicine. 365:1304–1314.

Kessous R, Davidson E, Meirovitz M, Sergienko R, & Sheiner E (2015). The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. Journal of Cancer Research and Clinical Oncology. 142:287–293.

Bethea TN, Rosenberg L, Hong C, Troester MA, Lunetta KL, Bandera EV, Schedin P, Kolonel LN, Olshan AF, Ambrosone CB, & Palmer (2015). JR. A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium. Breast Cancer Research. 17:22

Rodgers KM, Udesky JO, Rudel RA, & Brody JG (2017). Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environmental Research. 160:152–182.

Rudel RA, Attfield KR, Schifano JN, & Brody JG (2007). Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer. 109:2635–66.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100F: 2,3,7,8-TETRACHLORODIBENZO-para-DIOXIN, 2,3,4,7,8-PENTACHLORODIBENZOFURAN, AND 3,3′,4,4′,5-PENTACHLOROBIPHENYL. Lyon (FR); 2012.

Castaño-Vinyals G, D’Errico A, Malats N, & Kogevinas M (2004). Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occupational and Environmental Medicine. 61:e12--e12.

Kim JH, Moon JY, Park EY, Lee KH, & Hong YC (2011). Changes in oxidative stress biomarker and gene expression levels in workers exposed to volatile organic compounds. Industral Health. 49:8–14.

Niehoff NM, Gammon MD, Keil AP, Nichols HB, Engel LS, Sandler DP, & White AJ (2019). Airborne mammary carcinogens and breast cancer risk in the Sister Study. Environment International. 130:104897.

White AJ, O’Brien KM, Niehoff NM, Carroll R, & Sandler DP (2019). Metallic Air Pollutants and Breast Cancer Risk in a Nationwide Cohort Study. Epidemiology. 30:20–28.

Hart JE, Bertrand KA, Dupre N, James P, Vieira VM, Vopham T, Mittleman MR, Tamimi RM, & Laden F (2018). Exposure to hazardous air pollutants and risk of incident breast cancer in the nurses’ health study II. Environmental Health. 17:1–9.

Taiwo AM (2019). A review of environmental and health effects of organochlorine pesticide residues in Africa. Chemosphere. 220:1126–40.

Loomis D, Guyton K, Grosse Y, El Ghissasi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, & Straif K (2015). Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid. Lancet Oncology. 16:891–892.

Peplonska B, Stewart P, Szeszenia-Dabrowska N, Rusiecki J, Garcia-Closas M, Lissowska J, Bardin-Mikolajczak A, Zatonski W, Gromiec J, Brzeznicki S, Brinton LA, & Blair A. (2007). Occupation and breast cancer risk in Polish women: A population-based case-control study. American Journal of Industrial Medicine. 50:97–111.

Ekenga CC, Parks CG, D’Aloisio AA, Deroo LA, & Sandler DP (2014). Breast Cancer Risk after Occupational Solvent Exposure: the Influence of Timing and Setting. Cancer Research. 74:3076–3083.

Niehoff NM, Gammon MD, Keil AP, Nichols HB, Engel LS, Sandler DP, & White JA (2019). Airborne mammary carcinogens and breast cancer risk in the Sister Study. Environment International. 130:104897.

International Agency for Research on Cancer (IARC) (2017). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 110: Some Chemicals Used as Solvents and in Polymer Manufacture. Vol. 110. Lyon (FR): International Agency for Research on Cancer. 141–176 p.

Rudel RA, Attfield KR, Schifano JN, & Brody JG (2007). Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer. 109:2635–66.

Centers for Disease Control and Prevention (CDC), The National Institute for Occupational Safety and Health (NIOSH) (2019). Formaldehyde - Reproductive Health [Internet]. [cited 2022 Feb 16]. Available from:

IARC (2012). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100F-24: Benzene [Internet]. International Agency for Research on Cancer. [cited 2022 Jan 27]. Available from:

Costantini AS, Gorini G, Consonni D, Miligi L, Giovannetti L, & Quinn M (2009). Exposure to benzene and risk of breast cancer among shoe factory workers in Italy. Tumori. 95:8–12.

Breast Cancer Prevention Partners (BCPP) (2019). Vinyl Chloride at a Glance [Internet]. [cited 2022 Jan 29]. Available from:

Garcia E, Hurley S, Nelson DO, Hertz A, & Reynolds P (2015). Hazardous air pollutants and breast cancer risk in California teachers: A cohort study -No section-. Environmental Health. 14:1–14.

IARC. 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide) [Internet]. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 97. International Agency for Research on Cancer Press; 2008 [cited 2022 Jan 29]. Available from:

Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V, & Altieri A (2007). Carcinogenicity of 1, 3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. Lancet Oncology. 8:679–680.

Mikoczy Z, Tinnerberg H, Björk J, & Albin M (2011). Cancer Incidence and Mortality in Swedish Sterilant Workers Exposed to Ethylene Oxide: Updated Cohort Study Findings 1972–2006. International Journal of Environmental Research and Public Health. 2011, 8:2009–2019.

Kjaer TK & Hansen J (2009). Cancer incidence among a large cohort of female Danish registered nurses. Scandinavian Journal of Work, Environment & Health. 446–453.

Santi SA, Meigs ML, Zhao Y, Bewick MA, Lafrenie RM, & Conlon MS (2015). A case–control study of breast cancer risk in nurses from Northeastern Ontario, Canada. Cancer Causes Control. 26:1421–8.

Steenland K, Whelan E, Deddens J, Stayner L, & Ward E (2003). Ethylene oxide and breast cancer incidence in a cohort study of 7576 women (United States). Cancer Causes Control. 14:531–539.

Hengstler JG, Foth H, Gebel T, Kramer PJ, Lilienblum W, Schweinfurth H, Völkel W, Wollin K-M, & Gundert-Remy U (2011). Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Critical Reviews in Toxicology. 41:263–291.

Hsu YL, Hung JY, Tsai EM, Wu CY, Ho YW, Jian SF, Yen MC, Chang W-A, Hou MF, & Kuo P (2015). Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROa$α$ and S100A8/A9. Oncology Reports. 34:2889–900.

Tucker DK, Macon MB, Strynar MJ, Dagnino S, Andersen E, & Fenton SE (2015). The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure. Reproductive Toxicology. 54:26–36.

Dinwiddie MT, Terry PD, & Chen J (2014). Recent Evidence Regarding Triclosan and Cancer Risk. Internal Journal of Environmental Researchand Public Health. 11:2209–2217.

Henry ND & Fair PA (2013). Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. Journal of Applied Toxicology. 33:265–272.

Lee HR, Hwang KA, Nam KH, Kim HC, & Choi KC (2014). Progression of Breast Cancer Cells Was Enhanced by Endocrine-Disrupting Chemicals, Triclosan and Octylphenol, via an Estrogen Receptor-Dependent Signaling Pathway in Cellular and Mouse Xenograft Models. Chemical Research in Toxicology. 2014;27:834–842.

Stiel L, Adkins-Jackson PB, Clark P, Mitchell E, & Montgomery S (2016). A review of hair product use on breast cancer risk in African American women. Cancer Medicine. 5:597–604.

Heikkinen S, Pitkäniemi J, Sarkeala T, Malila N, & Koskenvuo M (2015). Does Hair Dye Use Increase the Risk of Breast Cancer? A Population-Based Case-Control Study of Finnish Women. PLoS One. 10:e0135190.

International Agency for Research on Cancer (2010). Monographs on the Evaluation of Carcinogenic Risks to Humans, volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. Lyon, France: IARC Press.

Llanos AAM, Rabkin A, Bandera EV, Zirpoli G, Gonzalez BD, Xing CY, Qin B, Lin Y, Hong C-C, Demissie K, & Ambrosone CB (2017). Hair product use and breast cancer risk among African American and White women. Carcinogenesis. 38:883–892.

Rodgers KM, Udesky JO, Rudel RA, & Brody JG (2018). Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environmental Research. 160:152–182.

Warner M, Mocarelli P, Samuels S, Needham L, Brambilla P, & Eskenazi B (2011). Dioxin exposure and cancer risk in the seveso women’s health study. Environmental Health Perspectives. 119:1700–1705.

Frentzel-Beyme R (2018). Occupational dioxin-exposure of women and breast cancer risk. Trends Med. 18.

Reynolds P, Hurley SE, Petreas M, Goldberg DE, Smith D, Gilliss D, Mahoney ME, & Jeffrey SS (2005). Adipose levels of dioxins and risk of breast cancer. Cancer Causes Control. 16:525–535.

Galloway TS (2015). Micro-and nano-plastics and human health. In: Bergmann M, Gutow L, Klages M, editors. Marine Anthropogenic Litter. Springer, Cham. 343–66.

Halden RU (2010). Plastics and Health Risks. Annual Review of Public Health. 31:179–194.

Lithner D, Damberg J, Dave G, & Larsson Å (2009). Leachates from plastic consumer products – Screening for toxicity with Daphnia magna. Chemosphere. 74:1195–1200.

Aslani H, Hosseini M-S, Mohammadi S, & Naghavi-Behzad M (2019). Drinking Water Disinfection By-products and Their Carcinogenicity, A Review of Unseen Crisis. International Journal of Cancer Management. 12.

Marcus PM, Savitz DA, Millikan RC, & Morgenstern H (1998). Female breast cancer and trihalomethane levels in drinking water in North Carolina. Epidemiology. 156–160.

Aschengrau A, Rogers S, & Ozonoff D (2003). Perchloroethylene-contaminated drinking water and the risk of breast cancer: Additional results from Cape Cod, Massachusetts, USA. Environmental Health Perspectives. 111:167–173.

McDonald TA & Komulainen H (2005). Carcinogenicity of the chlorination disinfection by-product MX. Journal of Environmental Science and Heal Part C. 23:163–214.

Font-Ribera L, Gràcia-Lavedan E, Aragonés N, Pérez-Gómez B, Pollán M, Amiano P, Zabala AJ, Vinyals G, Barceló A, Ardanaz E, Burgui R, Molina AJ, Villa TF, Acebo IG, Sotos TD, Moreno V, Tardon GF, Peiró R, Kogevinas M, & Villanueva CM (2018). Long-term exposure to trihalomethanes in drinking water and breast cancer in the Spanish multicase-control study on cancer (MCC-SPAIN). Environment International. 112:227–34.

Gallagher LG, Webster TF, Aschengrau A, & Vieira VM (2010). Using Residential History and Groundwater Modeling to Examine Drinking Water Exposure and Breast Cancer. Environmental Health Perspectives. 118:749–755.

Brody JG, Aschengrau A, McKelvey W, Swartz CH, Kennedy T, & Rudel RA (2006). Breast cancer risk and drinking water contaminated by wastewater: A case control study. Environmental Health: A Global Access Science Source. 5:1–11.

Dyer CA (2007). Heavy Metals as Endocrine-Disrupting Chemicals. In: Gore AC, editor. Endocrine-Disrupting Chemicals From Basic Research to Clinical Practice. 1st ed. Humana Press; 111–133.

Florea AM & Büsselberg D (2011). Metals and breast cancer: Risk factors or healing agents? Journalof Toxicology. 1–8.

Darbre PD (2006). Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. Journal of Applied Toxicology. 26:191–197.

Ragab A, Ragab AR, Farouk O, Aify MM, Attia AM, & Samanoudy AE (2014). The Role of Oxidative Stress in Carcinogenesis Induced By Metals in Breast Cancer Egyptian Females Sample at Dakahlia Governorate.Journal of Environmental & Analytical Toxicology. 4:207.

Siewit CL, Gengler B, Vegas E, Puckett R, & Louie MC (2010). Cadmium Promotes Breast Cancer Cell Proliferation by Potentiating the Interaction between ERα and c-Jun. Molecular Endocrinology. 24:981–992.

McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, & Newcomb PA (2006). Cadmium Exposure and Breast Cancer Risk. Journal of the National Cancer Institute. 98:869–73.

Mandriota SJ, Tenan M, Ferrari P, & Sappino AP (2016). Aluminium chloride promotes tumorigenesis and metastasis in normal murine mammary gland epithelial cells. International Journal of Cancer. 139:2781–90.

Carver A & Gallicchio VS (2017). Heavy metals and cancer. Cancer Causing Subst. 1–9.

Chen WY, Rosner B, Hankinson SE, Colditz GA, & Willett WC (2011). Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk. JAMA. 306:1884–90.

Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, & Tamimi RM (2013). Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk. Journal of the National Cancer Institute. 105:1571–1578.

Liu Y, Nguyen N, & Colditz GA (2015). Links between Alcohol Consumption and Breast Cancer: A Look at the Evidence: Womens Heal (London, England). 11:65–77.

Chen Z bo, An Y, Wang Z, Zhang B xun, & Liu L ying (2007). Tobacco-specific Carcinogen 4-(Methylnitrosoamino)-1-(3-pyridyl)-1-butanone(NNK) Activating ERK1/2 MAP Kinases and Stimulating Proliferation of Human Mammary Epithelial Cells. The Journal Chemistry Research in Chinese Universities. 23:76–80.

Kalantari-Dehaghi M, Parnell EA, Armand T, Bernard HU, & Grando SA (2015). The nicotinic acetylcholine receptor-mediated reciprocal effects of the tobacco nitrosamine NNK and SLURP-1 on human mammary epithelial cells. International Immunopharmacology. 29:99–104.

Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, David P, Pinder R, Ross RK, West D, Wright WE, & Riogas A (2004). Active Smoking, Household Passive Smoking, and Breast Cancer: Evidence From the California Teachers Study. Journal of the National Cancer Institute. 96:29–37.

Band PR, Le ND, Fang R, & Deschamps M (2002). Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet. 360:1044–1049.

Gram IT, Park SY, Kolonel LN, Maskarinec G, Wilkens LR, Henderson BE, & Merchand LL (2015). Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink AlcoholThe MEC Study. American Journal Epidemiology. 182:917–925.

Cui Y, Miller AB, & Rohan TE (2006). Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Research Treatment. 100:293–299.

Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, Stefanick ML, Tindle HA, Tong E, & Rohan TE (2011). Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. Bristish Medical Journal. 342:536.

DeRoo LA, Cummings P, & Mueller BA (2011). Smoking Before the First Pregnancy and the Risk of Breast Cancer: A Meta-Analysis. American Journal of Epidemiology. 174:390–402.

Dossus L, Boutron-Ruault MC, Kaaks R, Gram IT, Vilier A, Fervers B, Manjer J, Tjonneland A, Olsen A, Overvad K, Claude J, Boeing H, Steffen A, Trichopoulou A, Lagiou P, Sarantopoulou M, Palli D, Berrino F, Tumino R, Vineis P, Mattiello A, Mesquita HB, Duijnhoven FJB, Bakker MF, Peeters P, Weiderpass E, Bjerkaas E, Braaten T, Menéndez V, Antonio Agudo A, Sanchez M, Amiano P, Tormo M, Barricarte A, Butt S, Khaw K, Wareham N, Key TJ, Travis RC, Rinaldi S, McCormack V, Romieu I, Cox DG, Norat T, Riboli E, & Chapelon F. (2014). Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort. Internal Journal of Cancer. 134:1871–1888.

Park SY, Palmer JR, Rosenberg L, Haiman CA, Bandera E V, Bethea TN, Troester MA, Viscidi E, Kolonel LN, Olashan AF, & Ambrosone CH (2016). A case–control analysis of smoking and breast cancer in African American women: findings from the AMBER Consortium. Carcinogenesis. 37:607–15.

Aceves C, Anguiano B, & Delgado G (2005). Is Iodine A Gatekeeper of the Integrity of the Mammary Gland? J Mammary Gland Biol Neoplasia. 10.

Stoddard FR, Brooks AD, Eskin BA, & Johannes GJ (2008). Iodine Alters Gene Expression in the MCF7 Breast Cancer Cell Line: Evidence for an Anti-Estrogen Effect of Iodine. Internal Journal of Medical Sciences. 5:189.

Kaczor T (2014). Iodine and Cancer. National Medical Journal. 6.

Rappaport J (2017). Changes in Dietary Iodine Explains Increasing Incidence of Breast Cancer with Distant Involvement in Young Women. Journal of Cancer. 8:174.

Eskin BA, Anjum W, Abraham GE, Stoddard F, Prestrud AA, & Brooks AD (2005). Identification of breast cancer by differences in urinary iodine. Cancer Res. 65.

Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG, Yaylacl M, & Ozturk A (2003). Breast cancer in association with thyroid disorders. Breast Cancer Research. 5:R110.

Dong JY & Qin LQ (2011). Soy isoflavones consumption and risk of breast cancer incidence or recurrence: A meta-analysis of prospective studies. Breast Cancer Research Treatment. 125:315–323.

Andres S, Abraham K, Appel KE, & Lampen A (2011). Risks and benefits of dietary isoflavones for cancer. Critical Review Toxicology. 41:463–506.

He FJ & Chen JQ (2013). Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms. Food Science and Human Wellness. 2:146–161.

Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, Ji B-T, Gao J, Gao YT, & Zheng (2009). Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women’s Health Study. American Journal of Clinical Nutrition. 89:1920–1926.

Wu YC, Zheng D, Sun JJ, Zou ZK, & Ma ZL (2015). Meta-analysis of studies on breast cancer risk and diet in Chinese women. International Journal of Clinical and Experimental Medicine. 8:73.

Zhang M, Yang H, & Holman CDAJ (2009). Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status. Breast Cancer Research Treatment. 118:553–563.

Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, & Liu W (2009). Soy Food Intake and Breast Cancer Survival. JAMA. 302:2437–43.

Woo HD, Park KS, Ro J, & Kim J (2012). Differential Influence of Dietary Soy Intake on the Risk of Breast Cancer Recurrence Related to HER2 Status. Nutrition and Cancer. 64:198–205.

Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen MN, Bethke KP, Dew A, Coomes M, & Bergan RC. (2012). Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial. Cancer Prevention Research. 5:309–319.

Nagata C, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, Wakai K, Inoue M, Tsugane S, & Sasazuki S (2014). Soy Intake and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population. Japanese Journal of Clinical Oncology. 44:282–295


  • There are currently no refbacks.